SBIR/STTR Research Award

FRACTIONATION OF CENTROMERE REGIONS FROM CHROMOSOMAL DNA

Award identifier 56778523ea7120253d564ffb2d58ba7f422dd9e0baa60870dc7e2580e8bf64daAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,015

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CHROMATIN, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The characterization of heterochromatin, the highly repetitive, highly condensed regions of the genome, has lagged behind the characterization of the euchromatic, gene-rich regions. Heterochromatic regions provide important functions, including centromeric activity, which is required for proper distribution of the chromosomes during cell divisions. Using proprietary technology developed by its founders, Dr. Daphne Preuss and colleagues, Chromatin, Inc. will isolate heterochromatic DNA from a variety of crop species, analyze its sequence, and test it for centromere function by constructing an autonomous mini-chromosome vector. This research will provide important information about heterochromatin and centromeres in plants; interestingly, Arabidopsis centromeres contain repeats of a 180- nucleotide sequence, whereas mammalian centromeres contain repeats of a 171-nucleotide sequence. Thus, research on plant heterochromatin may inform studies of mammalian heterochromatin. Furthermore, the ultimate goal of this research is the development of an autonomous mini-chromosome vector, which will be a significant improvement over current transformation methods by allowing the introduction of multiple genes in a controlled regulatory environment. Thus, this research will provide important insight on heterochromatic composition and function and will also provide a valuable tool for research studying the functions of multiple genes. PROPOSED COMMERCIAL APPLICATION: The ultimate goal of this research is the development of an autonomous mini-chromosome vector, which will be a significant improvement over current transformation methods. This vector will allow the introduction of multiple genes, possibly including entire biosynthetic pathways, into plants. Moreover, the autonomy of this vector allows genes to be introduced in a controlled regulatory environment without alteration of the host genome. Possible applications include the synthesis of vitamins or pharmaceuticals in plants and research studying the function of multiple genes in combination.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.